{
    "clinical_study": {
        "@rank": "45035", 
        "arm_group": [
            {
                "arm_group_label": "Control", 
                "arm_group_type": "No Intervention", 
                "description": "Subjects assigned to the usual care group will receive general lifestyle recommendations as per their country standards of care."
            }, 
            {
                "arm_group_label": "Web", 
                "arm_group_type": "Experimental", 
                "description": "Access to a web-based lifestyle modification program of 6-month duration that covers all aspects of a healthy lifestyle including physical activity, nutrition and weight maintenance."
            }, 
            {
                "arm_group_label": "Web+", 
                "arm_group_type": "Experimental", 
                "description": "Access to a web-based lifestyle modification program of 6-month duration that covers all aspects of a healthy lifestyle including physical activity, nutrition and weight maintenance plus telephone counseling support by health coaches on a weekly or bi-weekly basis."
            }
        ], 
        "brief_summary": {
            "textblock": "To evaluate the effect of a 6-month web-based lifestyle modification program with and\n      without telephone counseling versus usual care in obese patients with cardiovascular risk\n      factors on:\n\n        -  Weight Loss\n\n        -  Waist circumference; blood pressure; total cholesterol, triglycerides, LDL-cholesterol,\n           HDL-cholesterol; glucose and hemoglobin A1c; C-reactive protein.\n\n        -  Physical activity and eating habits\n\n        -  Quality of life"
        }, 
        "brief_title": "Efficacy of a Web-based Lifestyle Modification Program in Obese Patients With Cardiovascular Risk Factors", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Obesity", 
        "condition_browse": {
            "mesh_term": "Obesity"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Male or female 25-70 years of age\n\n          2. Obese (BMI \u2265 30 kg/m2 and <40 kg/m2)\n\n          3. At least 2 cardiovascular risk factors (diabetes, hypertension or dyslipidemia) i)\n             Hypertension defined by a history of hypertension, treatment of hypertension or BP\n             values >140/90 mmHg in two consecutive office visits ii) High cholesterol defined by\n             an LDL-C \u2265130 mg/dL and/or HDL-C <40 mg/dL and triglycerides \u2265150 mg/dL iii) Type 2\n             Diabetes Mellitus defined by a history of diabetes, treatment of diabetes or fasting\n             glucose \u2265126 mg/dL in two consecutive office visits\n\n          4. Participant must be willing and able to provide written informed consent\n\n          5. Participant must be willing and able to comply with study related procedures\n\n          6. Participant must have access to Internet and e-mail\n\n        Exclusion Criteria:\n\n          1. Stage 1 or 2 on Patient Activation Measures tool\n\n          2. Weight change of more than 5 kg during the 3 months preceding the screening visit\n\n          3. History of bariatric surgery\n\n          4. Fasting Plasma Glucose at screening > 250 mg/dL (> 13.9 mmol/L)\n\n          5. Hemoglobin A1c at screening >8.5%\n\n          6. Treatment of type 2 diabetes with insulin (except for history of intermittent acute\n             use, no more than 2 weeks usage in previous 6 months)\n\n          7. Uncontrolled or inadequately controlled hypertension at the time of screening with\n             blood pressure >160/100 mmHg\n\n          8. Secondary hypertension\n\n          9. Changes in lipid, blood pressure or diabetes modifying agents including introduction,\n             change in dose or cessation in the 3 months prior to Screening Visit\n\n         10. Personal history of coronary heart disease, congestive heart failure, serious\n             arrhythmias and stroke\n\n         11. Cardiovascular, hepatic, neurological, endocrine disease, active malignant tumor or\n             other major systemic disease making implementation of the protocol or interpretation\n             of the study results difficult.\n\n         12. Presence of any condition (medical, psychological, social, or geographical), actual\n             or anticipated, that in the opinion of the Investigator would restrict or limit the\n             patient's successful participation for the duration of the study\n\n         13. Presence of history of cancer within the past five years with the exception of\n             adequately treated localized basal cell skin cancer or in situ uterine cervical\n             cancer\n\n         14. Use of systemic glucocorticoids (excluding topical application or inhaled forms) for\n             one week or more within 3 months prior to the time of screening\n\n         15. Use of any investigational agent (drug, biologic, device) within 3 months prior to\n             screening"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "25 Years"
        }, 
        "enrollment": {
            "#text": "350", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 9, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01664026", 
            "org_study_id": "PWeb123"
        }, 
        "intervention": [
            {
                "arm_group_label": "Web", 
                "description": "Access to a web-based lifestyle modification program of 6-month duration that covers all aspects of a healthy lifestyle including physical activity, nutrition and weight maintenance.", 
                "intervention_name": "Web-based lifestyle modification", 
                "intervention_type": "Behavioral"
            }, 
            {
                "arm_group_label": "Web+", 
                "description": "Access to a web-based lifestyle modification program of 6-month duration that covers all aspects of a healthy lifestyle including physical activity, nutrition and weight maintenance plus telephone counseling support by health coaches on a weekly or bi-weekly basis.", 
                "intervention_name": "Web-based lifestyle modification +", 
                "intervention_type": "Behavioral"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "August 10, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Buenos Aires", 
                    "country": "Argentina"
                }, 
                "name": "Clinica Bazterrica"
            }
        }, 
        "location_countries": {
            "country": "Argentina"
        }, 
        "number_of_arms": "3", 
        "official_title": "A 6-Month, Randomized Study to Evaluate the Efficacy of a Web-based Lifestyle Modification Program With and Without Telephone Counseling Support", 
        "other_outcome": [
            {
                "measure": "Changes in lifestyle behaviors (physical activity and eating habits)", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "measure": "Changes in quality of life", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }
        ], 
        "overall_official": {
            "last_name": "Andres Digenio, MD", 
            "role": "Study Director"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "Argentina: Human Research Bioethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Change in body weight from randomization to 6 months", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01664026"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Cl\u00ednica Bazterrica", 
            "investigator_full_name": "Arnaldo Angelino", 
            "investigator_title": "Jefe de Prevencion y Rehabilitacion", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Changes in waist circumference", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "measure": "Changes in blood pressure", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "measure": "Changes in lipid  parameters (total cholesterol, triglycerides, LDL-cholesterol, HDL-cholesterol)", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "measure": "Changes in glycemic parameters (glucose and hemoglobin A1c)", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "measure": "Changes in C-reactive protein", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }
        ], 
        "source": "Cl\u00ednica Bazterrica", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Cl\u00ednica Bazterrica", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "August 2012"
    }
}